Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cholesterol
Research
Epigenetic silencing lasts in mice, Chroma-sponsored study shows
Mouse data from a study sponsored in part by Chroma Medicine suggests that epigenetic gene silencing can suppress the target gene for nearly a year.
Helen Floersh
Feb 28, 2024 11:00am
FDA frees Verve's base editing therapy from clinical hold
Oct 23, 2023 6:30am
LIB's cholesterol-busting drug hits goal in 2nd phase 3 trial
Aug 29, 2023 6:30am
AstraZeneca returns to hypercholesterolemia via Chinese R&D pact
Jun 16, 2023 9:27am
FDA hands Verve list of demands for lifting gene editing hold
Dec 5, 2022 9:20am
Verily's Onduo slashes blood sugar in Type 2 diabetes patients
Nov 7, 2022 10:30am